Computational Prediction of the Optimal Oligomeric State for Membrane-inserted β-barrels of Protegrin-1 and Related Mutants

Overview

Journal J Pept Sci

Specialty Biochemistry

Date 2017 Apr 7

PMID 28382709

Citations 4

Authors

Richard Lipkin

Themis Lazaridis

Affiliations

Soon will be listed here.

Abstract

Protegrin-1 is a widely studied 18-residue β-hairpin antimicrobial peptide. Evidence suggests that it acts via a β-barrel pore formation mechanism, but the exact number of peptides comprising the pore state is unknown. In this study, we performed molecular dynamics simulations of β-barrels of protegrin and three related mutants (v14v16l, v14v16a, and r4n) in NCNC parallel topology in implicit membrane pores of varying radius and curvature for oligomeric numbers 6-14. We then identified the optimal pore radius and curvature values for all constructs and determined the total effective energy and the translational and rotational entropic losses. These, along with an estimate of membrane deformation free energy from experimental line tension values, provided an estimate of the overall energetics of formation of each pore state. The results indicated that oligomeric numbers 7-13 are generally stable, allowing the possibility of a heterogeneous pore state. The optimal oligomeric state for protegrin is the nonamer, shifting to higher numbers for the mutants. Protegrin, v14v16l, and r4n are stable as membrane-inserted β-barrels, but v14v16a seems much less so because of its decreased hydrophobicity. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.

Citing Articles

CHARMM at 45: Enhancements in Accessibility, Functionality, and Speed.

Hwang W, Austin S, Blondel A, Boittier E, Boresch S, Buck M J Phys Chem B. 2024; 128(41):9976-10042.

PMID: 39303207 PMC: 11492285. DOI: 10.1021/acs.jpcb.4c04100.

Experimental and Computational Characterization of Oxidized and Reduced Protegrin Pores in Lipid Bilayers.

Rodnin M, Vasquez-Montes V, Nepal B, Ladokhin A, Lazaridis T J Membr Biol. 2020; 253(3):287-298.

PMID: 32500172 PMC: 7360341. DOI: 10.1007/s00232-020-00124-3.

Insights into Membrane Translocation of Protegrin Antimicrobial Peptides by Multistep Molecular Dynamics Simulations.

Lai P, Kaznessis Y ACS Omega. 2018; 3(6):6056-6065.

PMID: 29978143 PMC: 6026836. DOI: 10.1021/acsomega.8b00483.

Transmembrane Pore Structures of β-Hairpin Antimicrobial Peptides by All-Atom Simulations.

Lipkin R, Pino-Angeles A, Lazaridis T J Phys Chem B. 2017; 121(39):9126-9140.

PMID: 28879767 PMC: 5686775. DOI: 10.1021/acs.jpcb.7b06591.

References

Jang H, Ma B, Lal R, Nussinov R . Models of toxic beta-sheet channels of protegrin-1 suggest a common subunit organization motif shared with toxic alzheimer beta-amyloid ion channels. Biophys J. 2008; 95(10):4631-42. PMC: 2576390. DOI: 10.1529/biophysj.108.134551. View

Jang H, Arce F, Ramachandran S, Capone R, Lal R, Nussinov R . Structural convergence among diverse, toxic beta-sheet ion channels. J Phys Chem B. 2010; 114(29):9445-51. PMC: 2908347. DOI: 10.1021/jp104073k. View

Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K . Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta. 1997; 1327(1):119-30. DOI: 10.1016/s0005-2736(97)00051-5. View

Lazaridis T . Structural Determinants of Transmembrane β-Barrels. J Chem Theory Comput. 2015; 1(4):716-22. DOI: 10.1021/ct050055x. View

Wade D, Boman A, Wahlin B, Drain C, Andreu D, Boman H . All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci U S A. 1990; 87(12):4761-5. PMC: 54197. DOI: 10.1073/pnas.87.12.4761. View

da Silva Jr A, Teschke O . Effects of the antimicrobial peptide PGLa on live Escherichia coli. Biochim Biophys Acta. 2003; 1643(1-3):95-103. DOI: 10.1016/j.bbamcr.2003.10.001. View

Brooks B, Brooks 3rd C, MacKerell Jr A, Nilsson L, Petrella R, Roux B . CHARMM: the biomolecular simulation program. J Comput Chem. 2009; 30(10):1545-614. PMC: 2810661. DOI: 10.1002/jcc.21287. View

Usachev K, Efimov S, Kolosova O, Klochkova E, Aganov A, Klochkov V . Antimicrobial peptide protegrin-3 adopt an antiparallel dimer in the presence of DPC micelles: a high-resolution NMR study. J Biomol NMR. 2015; 62(1):71-9. DOI: 10.1007/s10858-015-9920-0. View

Yang L, Weiss T, Lehrer R, Huang H . Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys J. 2000; 79(4):2002-9. PMC: 1301090. DOI: 10.1016/S0006-3495(00)76448-4. View

10.

Ben-Tal N, Honig B, Bagdassarian C, Ben-Shaul A . Association entropy in adsorption processes. Biophys J. 2000; 79(3):1180-7. PMC: 1301014. DOI: 10.1016/S0006-3495(00)76372-7. View

11.

Brown K, Hancock R . Cationic host defense (antimicrobial) peptides. Curr Opin Immunol. 2005; 18(1):24-30. DOI: 10.1016/j.coi.2005.11.004. View

12.

Gottler L, Bea R, Shelburne C, Ramamoorthy A, Marsh E . Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1. Biochemistry. 2008; 47(35):9243-50. DOI: 10.1021/bi801045n. View

13.

Huang H . Action of antimicrobial peptides: two-state model. Biochemistry. 2000; 39(29):8347-52. DOI: 10.1021/bi000946l. View

14.

Lam K, Wang H, Siaw T, Chapman M, Waring A, Kindt J . Mechanism of structural transformations induced by antimicrobial peptides in lipid membranes. Biochim Biophys Acta. 2011; 1818(2):194-204. DOI: 10.1016/j.bbamem.2011.11.002. View

15.

Ludtke S, He K, Heller W, Harroun T, Yang L, Huang H . Membrane pores induced by magainin. Biochemistry. 1996; 35(43):13723-8. DOI: 10.1021/bi9620621. View

16.

Jang H, Ma B, Nussinov R . Conformational study of the protegrin-1 (PG-1) dimer interaction with lipid bilayers and its effect. BMC Struct Biol. 2007; 7:21. PMC: 1858697. DOI: 10.1186/1472-6807-7-21. View

17.

Lipkin R, Lazaridis T . Implicit Membrane Investigation of the Stability of Antimicrobial Peptide β-Barrels and Arcs. J Membr Biol. 2014; 248(3):469-86. PMC: 4447622. DOI: 10.1007/s00232-014-9759-4. View

18.

Bradshaw J . Cationic antimicrobial peptides : issues for potential clinical use. BioDrugs. 2003; 17(4):233-40. DOI: 10.2165/00063030-200317040-00002. View

19.

Oren Z, Shai Y . Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 1999; 47(6):451-63. DOI: 10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F. View

20.

Oren Z, Lerman J, Gudmundsson G, Agerberth B, Shai Y . Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J. 1999; 341 ( Pt 3):501-13. PMC: 1220385. View